Open Access

Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin

  • Authors:
    • Sang Yoon Kang
    • Sung Jun Lee
    • Seung Ho Hong
    • Yoon Kyu Chung
    • Hyun Soo Oh
    • Sug Won Kim
    • Dong Jin Yim
    • Nam Keun Kim
  • View Affiliations

  • Published online on: July 8, 2010     https://doi.org/10.3892/mmr.2010.329
  • Pages: 741-747
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Genetic instability resulting from mutations in repair genes, defects in folic acid metabolism or DNA synthesis has been reported to contribute significantly to the development of skin cancer. The enzymes 5,10-methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase (TS) are essential participants in folic acid metabolism and DNA synthesis. Thus, the present case-control study was conducted to determine whether an association exists between the MTHFR/TS polymorphisms and squamous cell carcinoma (SCC) and/or basal cell carcinoma (BCC) among Korean individuals. The study subjects comprised 95 patients with SCC, 100 patients with BCC and 207 controls with no evidence of malignancy or pre-malignant lesions. Patients with skin cancer and control samples were analyzed for polymorphisms of the MTHFR or TS genes by means of polymerase chain reaction-restriction fragment length polymorphism. The MTHFR 677C>T and MTHFR 1298A>C polymorphisms showed no significance with regard to the development of SCC and BCC. However, within the 6 bp insertion (ins)/deletion (del) polymorphism in the 3'-untranslated region (3'-UTR) of the TS gene, the BCC group showed statistical significance with a 2.8-fold increased risk of cancer development [adjusted odds ratio (AOR)=2.821] in heterozygous mutations (0 bp/6 bp), 7.5-fold (AOR=7.539) in homozygous mutations (6 bp/6 bp) and 3-fold (AOR=3.079) upon combination of heterozygous mutations and homozygous mutations (0 bp/6 bp + 6 bp/6 bp). We thus conclude that the 6 bp ins/del polymorphism in the 3'-UTR is associated with increased risk of the development of skin cancer among Korean individuals with BCC.

Related Articles

Journal Cover

September-October 2010
Volume 3 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kang SY, Lee SJ, Hong SH, Chung YK, Oh HS, Kim SW, Yim DJ and Kim NK: Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin. Mol Med Rep 3: 741-747, 2010
APA
Kang, S.Y., Lee, S.J., Hong, S.H., Chung, Y.K., Oh, H.S., Kim, S.W. ... Kim, N.K. (2010). Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin. Molecular Medicine Reports, 3, 741-747. https://doi.org/10.3892/mmr.2010.329
MLA
Kang, S. Y., Lee, S. J., Hong, S. H., Chung, Y. K., Oh, H. S., Kim, S. W., Yim, D. J., Kim, N. K."Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin". Molecular Medicine Reports 3.5 (2010): 741-747.
Chicago
Kang, S. Y., Lee, S. J., Hong, S. H., Chung, Y. K., Oh, H. S., Kim, S. W., Yim, D. J., Kim, N. K."Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin". Molecular Medicine Reports 3, no. 5 (2010): 741-747. https://doi.org/10.3892/mmr.2010.329